Analyst Cory Jubinville, PhD of LifeSci Capital maintained a Buy rating on Rocket Pharmaceuticals (RCKT – Research Report), retaining the price ...

Rocket Pharmaceuticals (RCKT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Gil Blum ...

RP-L102, which the firm designed to treat a form of disease caused by FANCA mutations, is already under review with the European Medicines Agency.

Rocket's lentiviral (LV) vector-based hematology portfolio consists of late-stage programs for Fanconi Anemia (FA), a difficult-to-treat genetic disease that leads to bone marrow failure (BMF) and ...

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today ...

Mirae Asset Global Investments Co. Ltd. raised its position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) by 21.5% during the third quarter, according to its most recent filing with the ...

Our Brawlhalla tier list can help you pick your next main and keep up with the ever-changing meta in this popular platform ...

MOSCOW (AP) — A Russian rocket on Tuesday blasted off successfully to carry a pair of Iranian satellites into orbit, a launch that reflected growing cooperation between Moscow and Tehran.

Today, we will share and guide you through the process of how to redeem the exclusive Rocket League codes. So without any delay, let us take a look at the codes and various steps to redeem them.

that unprecedented sum will continue to grow through year's end — with space fans eyeing the calendar awaiting the debut flight of Blue Origin's New Glenn rocket. Crews at NASA's Kennedy Space ...